Regulation of alternative pre-mRNA splicing by the ERK MAP-kinase pathway

EMBO Journal

Volumn 20, Issue 15, 2001, Pages 4194-4203

  Weg Remers, Susanne ^a   Ponta, Helmut ^a   Herrlich, Peter ^a,b   König, Harald ^a  

^a KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF KARLSRUHE   (Germany)

Author keywords

Alternative splicing; CD44; MAP kinase; Signal transduction; T cells

Indexed keywords

HERMES ANTIGEN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; RAF PROTEIN; RAS PROTEIN;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; ENZYME ACTIVATION; EXON; GENE EXPRESSION REGULATION; IMMUNE RESPONSE; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA SPLICING; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ALTERNATIVE SPLICING; ANIMALS; ANTIGENS, CD44; CELLS, CULTURED; EXONS; GENE EXPRESSION REGULATION; GENE SILENCING; GENES, REPORTER; LUCIFERASES; MAP KINASE KINASE 1; MAP KINASE KINASE 2; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED BALB C; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN ISOFORMS; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-RAF; PROTO-ONCOGENE PROTEINS P21(RAS); RNA PRECURSORS; T-LYMPHOCYTES; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0035421277     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/20.15.4194     Document Type: Article

References (59)

1. Participation in normal immune responses of a splice variant of CD44 that encodes a metastasis-inducing domain
2. Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons
3. CD44 isoforms containing exon v3 are responsible for the presentation of heparin-binding growth factor
4. Serum-, TPA-, and Ras-induced expression from Ap-1/Ets-driven promoters requires Raf-1 kinase
5. Directing alternative splicing: Cast and scenarios
6. Regulation of alternative splicing of protein kinase C β by insulin
7. Mammalian MAP kinase signalling cascades
8. Inhibition of mitogenactivated protein kinase blocks T cell proliferation but does not induce or prevent anergy
9. JNK is required for effector T-cell function but not for T-cell activation
10. Stimulation of p21ras upon T-cell activation
11. Identification of a novel inhibitor of mitogenactivated protein kinase
12. Expression of CD44 isoforms in neuroblastoma cells is regulated by PI 3-kinase and protein kinase C
13. Ras regulation and function in lymphocytes
14. Multiple p21ras effector pathways regulate nuclear factor of activated T cells
15. p21ras initiates Rac-1 but not phosphatidyl inositol 3 kinase/PKB, mediated signaling pathways in T lymphocytes
16. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
17. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps
18. CD44 acts both as a growthand invasiveness-promoting molecule and as a tumor-suppressing cofactor
19. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain
20. p21ras couples the T cell antigen receptor to extracellular signal-regulated kinase 2 in T lymphocytes
21. Trans-acting factors regulate the expression of CD44 splice variants
22. Coupling of signal transduction to alternative pre-mRNA splicing by a composite splice regulator
23. Activated human lymphocytes and aggressive Non-Hodgkin lymphomas express a homologue of the rat metastasis-associated variant of CD44
24. Inhibition of v-rafc-fos expression and transformation by a kinase-defective mutant of the mitogen-activated protein kinase Erk2
25. Rac and Cdc42 induce actin polymerization and G1 cell cycle progression independently of p65PAK and the JNK/SAPK MAP kinase cascade
26. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
27. The expression of two splice variants of the Kv3.1 potassium channel gene is regulated by different signaling pathways
28. Alternative splicing of pre-mRNA: Developmental Consequences and mechanisms of regulation
29. A model system for activation-induced alternative splicing of CD45 pre-mRNA in T cells implicates protein kinase C and Ras
30. Expression and modulation of CD44 variant isoforms in humans
31. Transformation of mammalian cells by constitutively active MAP kinase
32. Heterogeneous ribonucleoprotein A1 is part of an exon-specific splice-silencing complex controlled by oncogenic signaling pathways
33. Two dominant inhibitory mutants of p21ras interfere with insulin-induced gene expression
34. CD44: Structure, function and association with the malignant process
35. RNA processing and human disease
36. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway
37. A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation
38. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons
39. Identification and characterization of three members of the human SR family of prem-RNA splicing factors
40. LARD: A new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing
41. A splice variant of CD44 expressed in the apical ectodermal ridge presents fibroblast growth factors to limb mesenchyme and is required for limb outgrowth
42. Growth factor-inducible alternative splicing of nontransmembrane phosphotyrosine phosphatase PTP-1B pre-mRNA
43. Variant exons v6 and v7 together expand the repertoire of glycosaminoglycans bound by CD44
44. Alternative pre-mRNA splicing: The logic of combinatorial control
45. Selective regulation of agrin mRNA induction and alternative splicing in PC12 cells by Ras-dependent actions of nerve growth factor
46. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronatebearing cells
47. CD44 variant isoforms in non-Hodgkin's lymphoma: A new independent prognostic factor
48. Splicing choice from ten variant exons establishes CD44 variability
49. Binding of cell-surface expressed CD44 to hyaluronate is dependent on splicing and cell type
50. Heparansulfate-modified CD44 promotes hepatocyte growth factor/scatter factor-induced signal transduction through the receptor tyrosine kinase c-Met
51. A 1538 MAP kinase inhibitor SB203580 inhibits CD28-dependent T cell proliferation and IL-2 production
52. Modulation of the immune response and tumor growth by activated Ras
53. 2-terminal kinase (Jnk) gene expression during T cell activation
54. Control of alternative splicing of potassium channels by stress hormones
55. Alternative splicing and differential expression of DT-diaphorase transcripts in human colon tumors and in peripheral mononuclear cells in response to mitomycin C treatment
56. 2+
57. Blocking lymphoma invasiveness with a monoclonal antibody directed against the β-chain of the leukocyte adhesion molecule (CD18)
58. Lymph node (but not spleen) invasion by murine lymphoma is both CD44- and hyaluronate-dependent
59. p38 mitogen-activated protein kinase mediates signal integration of TCR/CD28 costimulation in primary murine T cells